Novartis Pharma AG 13D and 13G filings for Erasca, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 5:02 pm Unchanged | 2024-12-31 | 13G | Erasca, Inc. ERAS | Novartis Pharma AG | 12,307,692 4.400% | 0 (Unchanged) | Filing |
| 2022-12-19 4:21 pm Purchase | 2022-12-09 | 13G | Erasca, Inc. ERAS | Novartis Pharma AG | 12,307,692 8.200% | 12,307,692 (New Position) | Filing |